1. Home
  2. CGBD vs CSTL Comparison

CGBD vs CSTL Comparison

Compare CGBD & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carlyle Secured Lending Inc.

CGBD

Carlyle Secured Lending Inc.

N/A

Current Price

$10.76

Market Cap

913.5M

Sector

Finance

ML Signal

N/A

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

N/A

Current Price

$26.37

Market Cap

940.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CGBD
CSTL
Founded
2012
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
913.5M
940.8M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CGBD
CSTL
Price
$10.76
$26.37
Analyst Decision
Hold
Strong Buy
Analyst Count
7
6
Target Price
$13.50
$47.17
AVG Volume (30 Days)
723.3K
422.3K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
14.97%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$344,229,000.00
Revenue This Year
$3.70
$2.10
Revenue Next Year
$1.07
$12.63
P/E Ratio
$10.36
N/A
Revenue Growth
N/A
3.66
52 Week Low
$10.87
$14.59
52 Week High
$17.34
$44.28

Technical Indicators

Market Signals
Indicator
CGBD
CSTL
Relative Strength Index (RSI) 30.79 27.94
Support Level N/A $21.77
Resistance Level $13.06 $34.97
Average True Range (ATR) 0.33 1.62
MACD -0.03 -0.16
Stochastic Oscillator 10.16 2.02

Price Performance

Historical Comparison
CGBD
CSTL

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: